Posts Tagged ‘public reporting’

October 15th, 2012

Selections from Richard Lehman’s Literature Review: October 15th

This week’s topics include PCI use in states with public reporting of outcomes; proneurotensin as a prognostic marker for CVD, diabetes, and mortality; vorapaxar for secondary prevention of thrombotic events in patients with previous MI; and atenolol vs. metoprolol for hypertension.

October 12th, 2012

PCI Public Reporting Programs: Incentivizing Better Decisions?

Joe Ross wonders what’s really behind the lower rates of PCI use in states that have public reporting programs.